-The Hindu Giving a distinct advantage to the urban English medium-educated students, the changed pattern of the Civil Services examination was notified by the Union Public Service Commission (UPSC) on Tuesday. Though the motto of the UPSC was to establish a level playing field with increased weightage for the General Studies component, introduction of an additional English language paper and restrictions on choosing languages as optional papers have put many aspirants in...

-PTI MUMBAI: Punjab, Delhi, Himachal Pradesh and Haryana have been ranked at the top of the Well Being Index (WBI), while southern states, Gujarat and most of the north-eastern states emerged as the most secure ones for women in the Female Security Index (FSI). This was found by Tata Strategic Management Group which analysed multiple government sources and surveys to publish its 2013 edition of Well Being Index (WBI) and Female Security...

-The Hindu Bangalore: Many corporates have responded positively to the government’s advice to increase their overall budget by 65 per cent for safety and security, especially of women, revealed a survey undertaken by ASSOCHAM Social Development Foundation (ASDF). According to the findings of the survey on ‘Women Safety and Security Budgets for 2013-14’, some corporates have hiked their budget by 65 per cent while others are in the process of doing it. The...

-The Business Standard Chennai: The Intellectual Property Appellate Board (IPAB) today upheld a compulsory licence issued by the Controller of Patents to Hyderabad-based Natco Pharma Ltd, a generic drug maker, to manufacture and sell a cancer drug of Bayer Corp in India. IPAB, however, made changes in the licence order by increasing the royalty payment to Bayer Corp for Nexavar, used to treat liver and kidney cancer, from six per cent to...

-The Hindu Bayer's plea dismissed by the Intellectual Property Appellate Board The Intellectual Property Appellate Board (IPAB) on Monday upheld the grant of compulsory licence (CL) to the Hyderabad-based Natco Pharma Limited, a generic drug maker, to produce and market Nexavar, a patented cancer drug of multinational pharma major Bayer Corporation. The order will pave the way for reduction in the prices of costly life saving drugs. Disposing an appeal filed by Bayer...